Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
Genes associated with T helper 17 cell differentiation and function.
High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Avonex approval application
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study.
A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
“Veterinary Medicines” page
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Estrogen and testosterone therapies in multiple sclerosis.
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »